Cardioprotective mechanisms and efficacy of colchicine, methotrexate, hydroxychloroquine, sulfasalazine and leflunomide in inflammatory rheumatic and musculoskeletal diseases (RMDs)
- DOI
- 10.1093/rheumatology/keag596
- Published
- 2026-10-23
- Container
- Rheumatology
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/rheumatology/keag596,
title = {Cardioprotective mechanisms and efficacy of colchicine, methotrexate, hydroxychloroquine, sulfasalazine and leflunomide in inflammatory rheumatic and musculoskeletal diseases (RMDs)},
author = {Rabia Agca and Sreen S Mohamed and Calin D Popa and Caroline van Durme and Harald E Vonkeman and Suat Simsek and Sjoerd Heslinga and Sander I van Leuven and Michael T Nurmohamed},
year = {2026},
journal = {Rheumatology},
doi = {10.1093/rheumatology/keag596},
url = {https://doi.org/10.1093/rheumatology/keag596}
}RIS
TY - JOUR TI - Cardioprotective mechanisms and efficacy of colchicine, methotrexate, hydroxychloroquine, sulfasalazine and leflunomide in inflammatory rheumatic and musculoskeletal diseases (RMDs) AU - Rabia Agca AU - Sreen S Mohamed AU - Calin D Popa AU - Caroline van Durme AU - Harald E Vonkeman AU - Suat Simsek AU - Sjoerd Heslinga AU - Sander I van Leuven AU - Michael T Nurmohamed PY - 2026 JO - Rheumatology DO - 10.1093/rheumatology/keag596 UR - https://doi.org/10.1093/rheumatology/keag596 ER -
APA
Agca, R., Mohamed, S. S., Popa, C. D., Durme, C. V., Vonkeman, H. E., Simsek, S., Heslinga, S., Leuven, S. I. V., & Nurmohamed, M. T. (2026). Cardioprotective mechanisms and efficacy of colchicine, methotrexate, hydroxychloroquine, sulfasalazine and leflunomide in inflammatory rheumatic and musculoskeletal diseases (RMDs). Rheumatology. https://doi.org/10.1093/rheumatology/keag596
Source records
- crossref · retrieved 2026-11-09T08:10:57.488Z